Cascadian Therapeutics, Inc. 4
4 · Cascadian Therapeutics, Inc. · Filed Jun 28, 2016
Insider Transaction Report
Form 4
Jackson Richard L.
Director
Transactions
- Award
Restricted Share Unit (RSU)
2016-06-24+54,347→ 54,347 total→ Common Stock (54,347 underlying)
Footnotes (2)
- [F1]Approximately 75% of each RSU represents a contingent right to receive approximately 0.75 share of the issuer's Common Stock upon vesting and approximately 25% represents a contingent right to receive cash upon vesting, which cash will be used to facilitate such holder's satisfaction of U.S. federal income tax obligations in connection with the vesting of the RSUs.
- [F2]100% vests on the one-year anniversary of the Transaction Date, subject to acceleration under certain circumstances.